Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06496178
Title A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Merus N.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | AUS | ARG


No variant requirements are available.